Lupus anticoagulant: a potential risk factor for complication following percutaneous transluminal coronary angioplasty.
A patient is described with antiphospholipid antibodies who died approximately 24 hr after an uncomplicated balloon angioplasty. Since the literature suggests a relationship between the presence of antiphospholipid antibodies and thromboses, we suggest that these antibodies may be a risk factor for abrupt closure after percutaneous transluminal coronary angioplasty.
Anglin
P
P
Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada.
Strauss
B H
BH
Brandwein
J M
JM
Watson
K R
KR
D000328:Adult; D015906:Angioplasty, Balloon, Coronary; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000150:complications / Q000401:mortality; D017023:Coronary Angiography; D017809:Fatal Outcome; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D008297:Male; D009203:Myocardial Infarction / Q000097:blood / Q000401:mortality / Q000628:therapy*; D012307:Risk Factors
D016682:Lupus Coagulation Inhibitor